Navigation Links
Pharmaceutical Medical Affairs Functions Get a Boost in Budget, Staffing
Date:4/22/2011

CHAPEL HILL, N.C., April 22, 2011 /PRNewswire/ -- The growing importance of the medical affairs function coincides with a company's need to manage rapidly changing regulatory requirements in today's biopharmaceutical industry.

This year, nearly one-third of companies anticipate an increase in medical affairs funding of more than 10 percent. However, a top challenge still on the minds of medical affairs executives is insufficient resources, including budget and headcount, for developing and maintaining an effective medical affairs group.

"Medical Affairs Resources, Structures & Trends," primary research conducted by Best Practices, LLC's, provides medical affairs executives with recent trends in budget and staffing resources, key challenges and top success factors for the function.

Download a complimentary white paper at http://www3.best-in-class.com/rr1060.htm that includes selected best practices drawn from extensive primary research with executives from 25 leading biopharmaceutical companies.

The full 40-page report contains more than 100 benchmark metrics and 20 executive narratives, providing medical affairs executives with recent trends in budget and staffing resources, key challenges and top success factors for the function.

Key topics of this primary research include:

  • Organizational structures
  • Budget allocation for medical affairs functions and outsourcing
  • Recent and anticipated changes in resource levels
  • Impact on medical affairs functions on company success
  • Key success factors and challenges for medical affairs

For more information on this study and other recent primary research studies, contact us at 919.403.0251 or at bestpractices@best-in-class.com.  

<
'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cumberland Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 4, 2011
2. Valeant Pharmaceuticals Responds to Cephalon Boards Letter
3. Jazz Pharmaceuticals Announces First Quarter 2011 Results Conference Call on May 3
4. Important Drug Product Notice: Luitpold Pharmaceuticals, Inc. Announces Temporary Suspension of Distribution and Manufacture of Drug Products
5. Onyx Pharmaceuticals Announces First Quarter 2011 Financial Results Teleconference and Webcast
6. Savient Pharmaceuticals to Hold First Quarter 2011 Financial Results
7. Fleming Pharmaceuticals Now Ready to Step Up Production of Nuclear Radiation Safeguard, ThyroShield®
8. Marinus Pharmaceuticals Announces Commencement of Phase 2 Trial of Ganaxolone for the Treatment of Posttraumatic Stress Disorder
9. China Botanic Pharmaceutical Announces Plans to Switch to Renewable Bio-Fuel - Straw Pellets
10. Hanmi Pharmaceuticals to Acquire the Rights for a Promising Phase II Anti-cancer Src Kinase/Pretubulin Dual Inhibitor from Kinex Pharmaceuticals, in Selected Asian Territories
11. Merrimack Pharmaceuticals Announces that Recruitment is Open in a Phase 1 Combination Study of MM-111 with Multiple Treatment Regimens in HER2 Positive Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... a privately held medical device company, announced today that ... ITOCHU Corporation (Tokyo Stock Exchange TYO: 8001) to sell ... cancer in Japan . ViewRay,s technology, ... only MRI-guided radiation therapy system that images and treats ...
(Date:1/22/2015)... Jan. 22, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" ... on Omega-3 therapies for cardiovascular disease and overall health is ... accomplishments in 2014 and its outlook for 2015 from the ... Shareholders, We would like to take this opportunity ...
(Date:1/22/2015)... , Jan. 22, 2015 Increasing sophistication among enterprise ... of localization purchasing in 2015, says Moravia ... a recent study by market research firm Common Sense ... solution for their translation and localization needs. "From a ...
Breaking Medicine Technology:ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7Moravia Sees Single-Sourcing as Key Localization Trend in 2015 2
... the launch of the endogo® HD, a mobile medical ... , The endogo® HD is a breakthrough device ... novel, web application; allowing physician-to-patient sharing, synchronization of patient ... secured connection to a referring doctor, anytime, anywhere. , ...
... Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTPD ... Ph.D., to the Company,s board of directors. Dr. Keltner ... a privately-held biotechnology company developing a late-stage, light-activated therapy ... also CEO of EPISTAT, an international healthcare technology transfer, ...
Cached Medicine Technology:Envisionier Announces the Launch of the endogo(R) HD, a Mobile Medical Imaging Platform for Capturing, Storing, and Sharing Endoscopic Multimedia 2Raptor Pharmaceutical Expands Board of Directors 2Raptor Pharmaceutical Expands Board of Directors 3Raptor Pharmaceutical Expands Board of Directors 4Raptor Pharmaceutical Expands Board of Directors 5
(Date:1/22/2015)... 23, 2015 The U.S. Pharmacopeial Convention ... Director of Clinical Pharmacy Services at North Carolina State’s ... of the 2015 Beal Award for Distinguished Volunteer Service—the ... relied on the contributions of volunteer experts to direct ...
(Date:1/22/2015)... Gabe’s Chemo Duck Program is pleased to announce ... ever created for kids with cancer. The Chemo Duck App, available ... filled with enjoyable games to help children of all ages living ... helps to keep kids entertained, educated and at ease while waiting ...
(Date:1/22/2015)... 22, 2015 Blue Cross and Blue Shield ... exemplify what it means to “Live Fearless.” , ... to share their stories about how they or someone they ... others by living in the moment. By telling these types ...
(Date:1/22/2015)... York (PRWEB) January 22, 2015 Thousand ... Fresenius Medical Care recalled its GranuFlo and NaturaLyte dialysis ... litigation underway in U.S. District Court, District of Massachusetts, ... January 20th, the Court has remanded a case filed ...
(Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 ... College of Sports Medicine flagship journal Medicine & ... with L-Citrulline before exercise may help reduce gastrointestinal ... exercise. 1 , Participants in the double-blind, ...
Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
... , , Program ... , , WASHINGTON, Sept. 1 With worries ... The National Education Association Health Information Network (NEA HIN) and The Clorox ... Starting September 2 through September 5, 2009, teachers nationwide can visit ...
... , , , PITTSBURGH, Sept. ... Press Club will welcome co-founder and former president of the renowned ... of Retired Persons (AARP) and Pittsburgh native William (Bill) D. Novelli. ... active as we get older, how to accomplish this, and what ...
... , , ELM GROVE, Wis., Sept. ... their efforts to prevent child abuse. During the month ... developed to raise awareness of the devastating effects of abuse and ... children suffer and more than two thousand die at the ...
... , , , ... Group, Inc. and M. Beacon Enterprises, LLC today announced ... services. Combining Approach Group,s healthcare and IT, and M. ... two companies now offer solutions that meet the urgent ...
... , , HOUSTON, Sept. ... is the first hospital in Houston to feature the CyberKnife((R)), ... non-cancerous tumors. , , The CyberKnife((R)) is the ... beams of high-dose radiation with extreme accuracy throughout the body, including the ...
... WELLESLEY HILLS, Mass., Sept. 1 Joseph F. Finn, ... Development Candidate Program will be part of the intellectual property ... , , The P2Y2, an Early Development ... treatment of constipation. , , The intellectual ...
Cached Medicine News:Health News:National Education Association Health Information Network (NEA HIN) and The Clorox Company Offer Free Disinfecting Wipes to Teachers Nationwide 2Health News:National Education Association Health Information Network (NEA HIN) and The Clorox Company Offer Free Disinfecting Wipes to Teachers Nationwide 3Health News:Compirion Joins the Fight Against Child Abuse 2Health News:Approach Group, Inc. and M. Beacon Enterprises, LLC Announce Strategic Partnership to Provide End-to-End Business Continuity Planning 2Health News:St. Luke's Episcopal Hospital First in Houston to Offer Revolutionary Noninvasive Tumor Treatment 2Health News:St. Luke's Episcopal Hospital First in Houston to Offer Revolutionary Noninvasive Tumor Treatment 3Health News:EPIX Pharmaceuticals, Inc. Announces the P2Y2 Gastrointestinal Early Development Candidate Program Will Be Part of the Intellectual Property Offered For Sale at the September 30, 2009 Auction 2
ThermalSeal RT (2mil) is Optically Clear for Real Time PCR and easy to apply. Works for all plates....
DMSO-resistant microplate sealing film...
Sealing tape, white Rayon, breathable, NS...
Sealing tape, slightly stiffer than Polyolefin tape. Certified RNase and DNase free....
Medicine Products: